Chondrogenic medium in combination with a c-Jun N-terminal kinase inhibitor mediates engineered cartilage regeneration by regulating matrix metabolism and cell proliferation.
JNK inhibitor
cartilage regeneration
chondrogenic medium
in vitro
in vivo
Journal
Regenerative biomaterials
ISSN: 2056-3418
Titre abrégé: Regen Biomater
Pays: England
ID NLM: 101652150
Informations de publication
Date de publication:
2023
2023
Historique:
received:
25
05
2023
revised:
11
07
2023
accepted:
28
08
2023
medline:
29
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
Cartilage tissue engineering is a promising strategy for repairing cartilage defects. However, achieving satisfactory cartilage regeneration
Identifiants
pubmed: 38020237
doi: 10.1093/rb/rbad079
pii: rbad079
pmc: PMC10640392
doi:
Types de publication
Journal Article
Langues
eng
Pagination
rbad079Informations de copyright
© The Author(s) 2023. Published by Oxford University Press.
Références
Acta Biomater. 2017 Jul 15;57:1-25
pubmed: 28088667
Exp Cell Res. 2003 Dec 10;291(2):282-8
pubmed: 14644151
ACS Appl Mater Interfaces. 2019 Oct 9;11(40):36359-36370
pubmed: 31509372
ACS Appl Mater Interfaces. 2018 Sep 19;10(37):31704-31715
pubmed: 30157627
Acta Biomater. 2020 Sep 15;114:31-52
pubmed: 32652223
Sci Rep. 2017 Jan 13;7:40489
pubmed: 28084417
Endocr Dev. 2011;21:102-115
pubmed: 21865759
Acta Biomater. 2017 May;54:321-332
pubmed: 28342879
J Biol Chem. 2001 Apr 13;276(15):11988-95
pubmed: 11278974
Endocr Dev. 2011;21:1-11
pubmed: 21865749
Bioact Mater. 2021 Dec 18;14:97-109
pubmed: 35310359
J Inflamm Res. 2021 Apr 13;14:1387-1402
pubmed: 33880054
Curr Opin Genet Dev. 2001 Feb;11(1):91-7
pubmed: 11163157
Front Bioeng Biotechnol. 2021 Jun 02;9:667161
pubmed: 34150731
Bioact Mater. 2021 Nov 12;13:149-160
pubmed: 35224298
Front Bioeng Biotechnol. 2022 May 24;10:871508
pubmed: 35685090
Biochim Biophys Acta. 2007 Aug;1773(8):1341-8
pubmed: 17306896
Cell Tissue Res. 2017 Oct;370(1):53-70
pubmed: 28413859
Front Cell Dev Biol. 2021 Mar 16;9:630678
pubmed: 33816478
Am J Transl Res. 2020 Jun 15;12(6):2903-2915
pubmed: 32655818
Mater Sci Eng C Mater Biol Appl. 2021 Jan;120:111628
pubmed: 33545814
J Cell Mol Med. 2018 Mar;22(3):1428-1442
pubmed: 29392844
Trends Cell Biol. 2015 Oct;25(10):592-600
pubmed: 26410405
Cell Cycle. 2016;15(2):196-212
pubmed: 26825227
Tissue Eng Part B Rev. 2019 Aug;25(4):357-373
pubmed: 30913997
Biomaterials. 2013 Sep;34(28):6706-16
pubmed: 23773816
Ann Plast Surg. 2022 May 1;88(3 Suppl 3):S296-S301
pubmed: 35513335
Ageing Res Rev. 2017 Nov;40:20-30
pubmed: 28774716
Acta Biomater. 2020 May;108:87-96
pubmed: 32268237
Front Cell Dev Biol. 2021 Jan 11;8:624337
pubmed: 33505975
Biotechnol Genet Eng Rev. 2017 Oct;33(2):144-172
pubmed: 29385962
Biomed Mater. 2018 Feb 02;13(2):025016
pubmed: 29125133
ACS Appl Mater Interfaces. 2016 Sep 21;8(37):24415-25
pubmed: 27559926
Int J Biol Macromol. 2021 Apr 1;175:495-515
pubmed: 33539959
Front Cell Dev Biol. 2021 Feb 26;9:638115
pubmed: 33718376
Tissue Eng Part B Rev. 2022 Feb;28(1):206-245
pubmed: 33470169
J Recept Signal Transduct Res. 2017 Oct;37(5):431-436
pubmed: 28812968
J Tissue Eng Regen Med. 2018 Apr;12(4):1123-1132
pubmed: 29139602
Genes Cancer. 2017 Sep;8(9-10):682-694
pubmed: 29234486
Tissue Eng Part A. 2021 Jun;27(11-12):748-760
pubmed: 33108972
Cell Biol Int. 2018 Jul;42(7):756-768
pubmed: 29418027
Curr Top Dev Biol. 2019;133:25-47
pubmed: 30902255
Annu Rev Immunol. 1993;11:331-60
pubmed: 8476565